Researchers Discover New Leukemia-Killing Compounds; Rice, MD Anderson Study Highlights Potential of Mitochondria-Targeted Chemotherapies

Researchers from Rice University and the University of Texas MD Anderson Cancer Center have discovered potential new drugs that work in concert with other drugs to deliver a deadly one-two punch to leukemia. The potential drugs are still years away from being tested in cancer patients, but a recently published study (June 7, 2022) in the journal Leukemiahighlights their promise and the innovative methods that led to their discovery. The article is titled “Novel Mitochondria-Targeting Compounds Selectively Kill Human Leukemia Cells.”